Last reviewed · How we verify

NCT06354192

Precision Nudging for Hypertension Management: Observational Study

Recruiting now Last updated 25 November 2025
What this trial tests

trial testing Precision Nudging for Hypertension Management in Hypertension in 12,000 participants. Currently enrolling.

Timeline
1 May 2024
Primary endpoint
1 April 2026
1 November 2026

Quick facts

Lead sponsorLirio
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment12,000
Start date1 May 2024
Primary completion1 April 2026
Estimated completion1 November 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Lirio

Who can join

18 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the proposed observational study is to explore the relations between data-driven personalization and equitable health outcomes in a digital health intervention (DHI) for hypertension management. In the current intervention, behavioral reinforcement learning is applied to personalize intervention content to maximize the behavioral outcomes of three target behaviors critical for effective hypertension management: clinical encounters, medication adherence, and self-monitoring of blood pressure (SMBP).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Lirio trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06354192.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing